ID SOLUTIONS develops, produces and markets innovative in vitro diagnostic tools in the field of oncology and infectious diseases.
Founded in 2016 and ISO 13485:2016 certified, ID SOLUTIONS is located in Montpellier (France).
The company develops standardized and innovative solutions for cancer diagnosis by digital PCR from liquid biopsy samples, recovering circulating and/or FFPE tumor DNA, recovering genomic tumor DNA.
ID SOLUTIONS has also become a major contributor to the fight against COVID-19 in France by providing several RT-PCR diagnostic solutions on the market. The company offers a wide range of rapid and robust solutions, including multiplexing and typing kits for variants of interest.
We recently launched our Infectious Disease line to complement the COVID-19 line and help our customers continue to support their patients with several multiplex qPCR solutions covering various diseases around women's health or gastrointestinal diseases.
iSolutions™ HPV Fullplex qPCR
High-risk human papillomavirus viral DNA detection kit by RT-qPCR
ID™ SARS-CoV-2 / VOC Revolution Pentaplex
Real-time RT-PCR method for detection of SARS-CoV-2 RNA and screening of L452R, K417N and E484K mutations RNA
oSolutions™ EGFR 4 exons digital PCR
Most multiplexed and sensitive tool for EGFR mutation detection by 6-color Crystal Digital PCR™